ALLK: Allakos Therapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Tashqi CRO tarmoqlari orqali xarajatlarni optimallashtirish Allakos Inc. (ALLK) kompaniyasiga mahsulotlarni bozorga chiqarishni tezlashtirish imkonini berdi va ushbu tendentsiya narxlar dinamikasida aks etgan. Daromadlar og'ir allergiyalarga qarshi kurashish uchun antitanachalar ishlab chiqishga asoslangan, lireltelimabning gastritni davolashda qo'llanilishi esa yangi immunologik standartni belgilaydi. O'sish kompaniyasining past baholanganlik metriki joriy baholash balansini vizuallashtiradi, bunda 0.00 ko'rsatkichning yangi qiymatiga aylanadi.
Allakos Inc. (ALLK) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Allakos Inc.|ALLK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi allakos.com|ALLK - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Allakos Therapeutics|ALLK - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Allakos|Tezkor likvidlik allakos.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ALLK - Kompaniyaning sof foydasi|Kutilayotgan foyda Allakos Inc.|ALLK - P/E multiplikatori|Forvard P/E multiplikatori allakos.com|ALLK - Narxning foydaga va o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Allakos Therapeutics|ALLK - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Allakos|ALLK - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi allakos.com|ALLK - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Allakos Inc.
Kompaniyaning umumiy tahlili:ALLK - Allakos Inc
Allakos Inc. (ALLK) kompaniyasining investitsiya jozibadorligi hozirda lirentelimabning klinik sinovlari muvaffaqiyatsiz yakunlanganidan keyingi inqirozdan chiqib ketish qobiliyatiga bog'liq. Ushbu ko'rsatkich P/E bozor koeffitsientini sof foyda dinamikasi bilan solishtiradi va kapitalning suyulishi xavfi yuqori bo'lgan sharoitda biznes kengayish sur'atlari joriy aksiya narxini oqlash-oklamasligini aniqlash uchun past baholangan o'sish kompaniyalarini identifikatsiya qilishda ushbu indikatorni qo'llaydi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|PHVS - PEG multiplikatori|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|TRML (tourmalinebio.com) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|Narxning foydaga va o‘sish sur’atiga nisbati PHAR|PEG multiplikatori NKTR|PEG multiplikatori Upstream Pharma (UPB)|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|PEG multiplikatori immunome.com IMNM|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda KalVista Pharma|Septerna Corp (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|PVLA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori SVRA|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Astria Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|RAPT: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Aerovate - PEG multiplikatori|aclaristx.com (ACRS) - Narx-foyda va o‘sish multiplikatori|KYTX (Kyverna Therapeutics, Inc.) - Narx-foyda va o‘sish multiplikatori|TLSA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|PEG multiplikatori Ventyx Biosciences, Inc|Narxning foydaga va o‘sish sur’atiga nisbati Theratechnologies Inc. (THTX)|Narxning foydaga va o‘sish sur’atiga nisbati AVTX (avalotx.com)|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|Agenus, Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|CLYM - Narxning foydaga va o‘sish sur’atiga nisbati|ZURA - PEG multiplikatori|aTyr Pharma, Inc. (ATYR) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ADAG (Adagene Inc.)|IMA (ImageneBio) - PEG multiplikatori|STTK: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori EQ|PEG multiplikatori connectbiopharm.com (CNTB)|Narxning foydaga va o‘sish sur’atiga nisbati Immunic IMUX|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ATRA|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|X4 Pharmaceuticals Inc. (XFOR) - Narx-foyda va o‘sish multiplikatori|ACET: PEG multiplikatori|Celularity (CELU) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori INMB|BRNS: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori KZR|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati SAB Biotherapeutics Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Akari Therapeutics plc AKTX|ENLV - Narx-foyda va o‘sish multiplikatori|QTTB - Narxning foydaga va o‘sish sur’atiga nisbati|geovax.com (GOVX) - Narx-foyda va o‘sish multiplikatori|EDSA (Edesa Biotech) - Narx-foyda va o‘sish multiplikatori|iBio Inc (IBIO) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Carisma Therapeutics Inc|O‘sishni hisobga olgan narx-foyda koeffitsiyenti XTLB (XTL Bio)|PEG multiplikatori BOLT|HCWB - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori APVO (Aptevo Therapeutics Inc.)|PEG multiplikatori aimimmuno.com AIM|ADTX - Narxning foydaga va o‘sish sur’atiga nisbati|GRI: Narxning foydaga va o‘sish sur’atiga nisbati|XORTX Therapeutics Inc. (XRTX) - Narxning foydaga va o‘sish sur’atiga nisbati|HIND (reshapelifesciences.com) - Narxning foydaga va o‘sish sur’atiga nisbati|REVB (Revelation Biosciences, Inc.) - PEG multiplikatori|PEG multiplikatori Indaptus Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati Scinai (SCNI)|PEG multiplikatori calcimedica.com (CALI)|Narxning foydaga va o‘sish sur’atiga nisbati Affimed N.V. AFMD|HOOKIPA Pharma, Inc. (HOOK) - O‘sish sur’atiga tuzatilgan narx-foyda|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics Inc ITOS|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TC BioPharm Ltd - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|THRD (Third Harmonic Bio) - PEG multiplikatori
